Cite
HARVARD Citation
Alba, M. et al. (2021). Efficacy and safety of glucagon‐like peptide‐1/glucagon receptor co‐agonist JNJ‐64565111 in individuals with obesity without type 2 diabetes mellitus: A randomized dose‐ranging study. Clinical obesity. 11 (2), p. n/a. [Online].